About: Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome
Creator	Armstrong, Paul Bowsman, Lenden Chan, Mark Duffin, Kevin Fox, Keith Grass, Elizabeth Gregory, Simon Haas, Joseph Kwee, Lydia Neely, Megan Ohman, E. Roe, Matthew Shah, Svati White, Harvey
Source	PMC
abstract	The genomic regulatory networks underlying the pathogenesis of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) are incompletely understood. As intermediate traits, protein biomarkers report on underlying disease severity and prognosis in NSTE-ACS. We hypothesized that integration of dense microRNA (miRNA) profiling with biomarker measurements would highlight potential regulatory pathways that underlie the relationships between prognostic biomarkers, miRNAs, and cardiovascular phenotypes. We performed miRNA sequencing using whole blood from 186 patients from the TRILOGY-ACS trial. Seven circulating prognostic biomarkers were measured: NH(2)-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein, osteopontin (OPN), myeloperoxidase, growth differentiation factor 15, monocyte chemoattractant protein, and neopterin. We tested miRNAs for association with each biomarker with generalized linear models and controlled the false discovery rate at 0.05. Ten miRNAs, including known cardiac-related miRNAs 25-3p and 423-3p, were associated with NT-proBNP levels (min. P = 7.5 × 10(−4)) and 48 miRNAs, including cardiac-related miRNAs 378a-3p, 20b-5p and 320a, -b, and -d, were associated with OPN levels (min. P = 1.6 × 10(−6)). NT-proBNP and OPN were also associated with time to cardiovascular death, myocardial infarction (MI), or stroke in the sample. By integrating large-scale miRNA profiling with circulating biomarkers as intermediate traits, we identified associations of known cardiac-related and novel miRNAs with two prognostic biomarkers and identified potential genomic networks regulating these biomarkers. These results, highlighting plausible biological pathways connecting miRNAs with biomarkers and outcomes, may inform future studies seeking to delineate genomic pathways underlying NSTE-ACS outcomes.
has issue date	2019-10-01(xsd:dateTime)
bibo:doi	10.1152/physiolgenomics.00033.2019
bibo:pmid	31530226
has license	no-cc
schema:url	https://doi.org/10.1152/physiolgenomics.00033.2019
resource representing a document's title	Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome
has PubMed Central identifier	PMC7054637
has PubMed identifier	31530226
schema:publication	Physiol Genomics
resource representing a document's body	covid:PMC7054637#body_text
is schema:about of	named entity 'circulating' named entity 'osteopontin' named entity 'Indianapolis' named entity 'miRNAs' named entity 'Agilent' named entity 'GWAS' named entity 'mouse model' named entity 'serum' named entity 'clopidogrel' named entity 'NT-proBNP' named entity 'biomarkers' named entity 'Aventis' named entity 'NT-proBNP' named entity 'ACS' named entity 'expression levels' named entity 'amino acid' named entity '5.5' named entity 'mRNA' named entity 'biological process' named entity 'biomarker' named entity 'prion diseases' named entity 'NT-proBNP' named entity 'polypeptide' named entity 'biomarkers' named entity 'confounder' named entity 'causality' named entity 'miRNA' named entity 'ACS' named entity 'Sanofi' named entity 'Statistical analysis' named entity 'biomarkers' named entity 'biomarkers' named entity 'Sanofi' named entity 'Merck Sharpe & Dohme' named entity 'carcinogenesis' named entity 'plasma' named entity 'cellular processes' named entity 'miRNAs' named entity 'technical replicates' named entity 'FDR' named entity 'clinical trial' named entity 'ethanol precipitation' named entity 'Aligned reads' named entity 'NT-proBNP' named entity 'biomarker' named entity 'biomarkers' named entity 'prasugrel' named entity 'phenotypes' named entity 'microcalcification' named entity 'immunoassays' named entity 'exact mechanism' named entity 'regulate gene expression' named entity 'Daiichi Sankyo' named entity 'ICAM-1' named entity 'unstable angina' named entity 'Illumina' named entity 'high-sensitivity C-reactive protein' named entity 'cardiovascular events' named entity 'MCP1' named entity 'ACS' named entity 'monocyte chemoattractant protein 1' named entity 'ACS' named entity 'mRNA' named entity 'miRNAs' named entity 'B-type natriuretic peptide' named entity 'genomic studies' named entity 'miRNAs' named entity 'chemoattractant' named entity 'biological pathways'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software